Related Experiment Videos
Abstract:
Pseudomonas species are highly versatile organisms with genetic and physiologic capabilities that allow them to flourish in environments hostile to most pathogenic bacteria. Within the lung of the patient with cystic fibrosis, exposed to a number of antimicrobial agents, highly resistant clones of Pseudomonas are selected. These may have acquired plasmid-mediated genes encoding a variety of beta-lactamases or aminoglycoside modifying enzymes. Frequently these resistance determinants are on transposable elements, facilitating their dissemination among the population of bacteria. Mutations in chromosomal genes can also occur, resulting in constitutive expression of normally repressed enzymes, such as the chromosomal cephalosporinase of Pseudomonas aeruginosa or Pseudomonas cepacia. These enzymes may confer resistance to the expanded-spectrum beta-lactam drugs. Decreased cellular permeability to the beta-lactams and the aminoglycosides also results in clinically significant antibiotic resistance. The development of new drugs with anti-Pseudomonas activity, beta-lactam agents and the quinolones, has improved the potential for effective chemotherapy but has not surpassed the potential of the organisms to develop resistance.
Insights
Pseudomonas bacteria develop antibiotic resistance through gene acquisition and mutations, even with new drugs. This versatility challenges cystic fibrosis lung infections.
Area of Science:
- Microbiology
- Infectious Diseases
- Genetics
Background:
- Pseudomonas species exhibit remarkable adaptability, thriving in harsh environments.
- In cystic fibrosis patients, Pseudomonas infections face antimicrobial pressure, selecting for resistant strains.
Purpose of the Study:
- To explore the mechanisms by which Pseudomonas species develop antibiotic resistance.
- To understand the genetic and physiological basis of Pseudomonas resistance in cystic fibrosis.
Main Methods:
- Analysis of genetic mechanisms including plasmid-mediated genes (beta-lactamases, aminoglycoside modifying enzymes) and transposable elements.
- Investigation of chromosomal gene mutations leading to enzyme overproduction (e.g., cephalosporinase).
- Assessment of reduced cellular permeability as a resistance factor.
Main Results:
- Pseudomonas resistance is mediated by acquired genes (beta-lactamases, aminoglycoside modifying enzymes) often on transposable elements.
- Chromosomal mutations can lead to constitutive expression of resistance enzymes, like cephalosporinase.
- Decreased drug permeability also contributes significantly to antibiotic resistance.
Conclusions:
- Pseudomonas possesses diverse resistance strategies, including genetic exchange and chromosomal alterations.
- Despite new antibiotics (beta-lactams, quinolones), Pseudomonas's resistance development capacity remains a significant clinical challenge.